AstraZeneca partners with Beansprout Networks to help children with asthma
"Pediatricians on our network continually cite asthma as one of the most common chronic conditions they treat," said Ron Lipof, Chief Strategic Officer at Beansprout. "The new asthma content area on the Beansprout Network is a direct response to the needs of our professionals and their families. Beansprout Networks' online asthma guide provides comprehensive information about the condition for families and pediatricians."
According to The Asthma and Allergy Foundation of America, the number of children younger than five with asthma has increased by 160% in the past 15 years. It also has been reported that asthma is the leading cause of chronic illness in youths under the age of 17 in the United States.
"Beansprout is thrilled to be working with AstraZeneca, a leader in the development of asthma medicines," Lipof said. "The sponsorship from AstraZeneca will enable us to provide, via the Internet, a steady flow of important asthma information that families and physicians can easily and quickly access to better understand and manage the disease in children."
"We are proud to partner with Beansprout, as it exemplifies the kind of innovative educational resource that AstraZeneca supports in our commitment to help families and physicians improve the lives and health of children and infants with asthma," said Frank Casty, Executive Director of Respiratory and Inflammation at AstraZeneca.